A Study of the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Janssen Research & Development, LLC
Start Date
October 8, 2020
End Date
November 1, 2022
Administered By
School of Medicine
Awarded By
Janssen Research & Development, LLC
Start Date
October 8, 2020
End Date
November 1, 2022